Skip to main content

Table 2 Operative data and postoperative complications of LDKT recipients

From: Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation

  

Patient groups according to moon phases/moon sign Libra

  

P-value*

 

n (%) a

New moon

Waxing moon

Full moon

Waning moon

Moon sign Libra

 

Number of patients

278 (100.0)

33 (100.0)

111 (100.0)

32 (100.0)

102 (100.0)

17 (100.0)

 

Duration of operation (min.) b

160 [65–345]

155 [120–345]

160 [90–280]

155 [65–295]

160 [99–335]

160 [120–265]

0.532

Graft placement c:

 R-L

133 (47.8)

16 (48.4)

58 (52.3)

17 (53.1)

42 (41.2)

11 (64.7)

0.358

 L-R

91 (32.7)

13 (39.4)

32 (28.8)

9 (28.1)

37 (36.3)

4 (23.5)

0.530

 L-L

23 (8.3)

3 (9.1)

8 (7.2)

2 (6.3)

10 (9.8)

1 (5.9)

0.883

 R-R

31 (11.2)

2 (6.1)

12 (10.8)

4 (12.5)

13 (12.7)

1 (5.9)

0.756

Hospital length of stay (days) b

18 [1–65]

20 [7–43]

17.5 [5–65]

16.5 [7–58]

18 [1–53]

21 [6–32]

0.851

General complications during inhospital stay d,e

12 (4.3)

1 (3.0)

4 (3.6)

2 (6.3)

5 (4.9)

0 (0)

0.887

Surgical complications during inhospital stay f

59 (21.2)

10 (30.3)

23 (20.7)

6 (18.8)

20 (19.6)

5 (29.4)

0.589

Relaparotomy

49 (17.6)

8 (16.2)

18 (16.2)

6 (18.8)

17 (16.7)

4 (23.5)

0.744

Rejection episodes g

56 (20.1)

8 (24.2)

24 (21.6)

8 (25.0)

16 (15.7)

1 (5.9)

0.527

Delayed graft function h

26 (9.4)

1 (3.0)

11 (9.9)

2 (6.3)

12 (11.8)

0 (0)

0.447

Long-term surgical complications i (>90 days)

25 (9.0)

2 (6.1)

11 (9.9)

3 (9.4)

9 (8.8)

1 (5.9)

0.925

Mortality:

 (<30 days)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

 

 (<90 days)

1 (0.4)

0 (0)

1 (0.9)

0 (0)

0 (0)

0 (0)

 

Graft loss:

 (<30 days)

4 (1.4)

0 (0)

2 (1.8)

1 (3.1)

1 (1.0)

1 (5.9)

 

 (<90 days)

5 (1.8)

0 (0)

2 (1.8)

1 (3.1)

1 (1.0)

1 (5.9)

 
  1. KT kidney transplantation, LDKT living donor kidney transplantation
  2. * p-values are calculated for moon phases only.
  3. avalues are number (percentage) unless indicated otherwise
  4. bvalues are median [range]
  5. cL = left, R = right, the first letter indicates the kidney, the second letter indicates the placement side
  6. dincluding cardiac events, respiratory events, multiorgan failure and gastrointestinal bleeding
  7. esome patients had more than one complication
  8. fincluding vascular complications, ureteral complications, events of graft rupture and dislocation, developmant of lymphocele, peritonitis, postoperative hemorrhage, events of fascial dehiscence, superficial and deep wound infection
  9. gall rejection episodes were biopsy-proven
  10. hneed for dialysis in the first 7 days after transplant and/or the presence of biopsy-proven acute tubular necrosis (ATN)
  11. iincluding vascular, urologic complications, fascial dehiscence, hernia